You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 270 No. 24, December 22, 1993 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Law and Medicine
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (18)
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Daubert v Merrell Dow

The Supreme Court Tackles Scientific Evidence in the Courtroom

Jay A. Gold, MD, JD, MPH; Miles J. Zaremski, JD; Elaine Rappaport Lev, JD; Deborah H. Shefrin, JD

JAMA. 1993;270(24):2964-2967.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

ON JUNE 28, 1993, the US Supreme Court handed down a decision that, in the words of one commentator, "could affect almost every piece of litigation in the Federal courts from this point forward."1 The decision in Daubert v Merrell Dow Pharmaceuticals2 sets forth criteria that federal courts must follow in admitting scientific evidence or excluding it from consideration by juries. While the decision will not apply directly to state courts, states are likely to look to the High Court for guidance. This article will analyze the decision and discuss its implications for medicine, medical publishing, and expert testimony.

THE CASE

The drug for morning sickness, Bendectin (doxylamine), was driven off the market in 1983 by the pressure of lawsuits asserting that it caused birth defects. Before Bendectin was taken off the market, millions of women had used it.3 Of 30 published epidemiologic studies involving over 130 . . . [Full Text PDF of this Article]


Author Affiliations

From the American College of Legal Medicine, Milwaukee, Wis (Dr Gold), and Arnstein & Lehr, Chicago III (Mr Zaremski and Mss Lev and Shefrin). Dr Gold is now with the Wisconsin Peer Review Organization, Madison, and the Department of Preventive Medicine and the Center for the Study of Bioethics, Medical College of Wisconsin, Milwaukee.


Footnotes

Reprint requests to WIPRO, 2909 Landmark PI, Madison, WI 53713 (Dr Gold).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1993 American Medical Association. All Rights Reserved.